Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Geno R&D AS
AS
Active
Org 993130532
Storhamargata 44, 2317
Hamar
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2008 · 17 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Geno R&D AS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
NOK millions
24M
18M
12M
6M
0M
2020: 0M
0M
2020
2021: 7M
7M
2021
2022: 3M (-57% vs 2021)
3M
-57%
2022
2023: 15M (+400% vs 2022)
15M
+400%
2023
2024: 19M (+27% vs 2023)
19M
+27%
2024
EBITDA
NOK millions
0M
0M
0M
-1M
-1M
2020: 0M
0M
2020
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
Income statement
NOK thousands
Item
2024
2023
2022
2021
2020
Revenue
18 885
14 917
3 100
7 280
0
Staff expenses
−0
−0
−0
−0
−0
EBITDA
−57
−139
−22
−18
−17
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
−57
−139
−22
−18
−17
Net financials
221
122
36
1
55
Profit before tax
164
−18
14
−17
37
Tax
−0
−0
−0
552
8
Net profit
164
−18
14
−569
29
Balance sheet
NOK thousands
Item
2024
2023
2022
2021
2020
Total assets
16 035
10 720
2 720
12 843
2 174
Equity
1 766
1 602
1 619
1 605
2 174
Long-term debt
0
0
0
0
0
Short-term debt
14 268
9 119
1 100
11 238
0
Total debt
14 268
9 119
1 100
11 238
0
Financial ratios
5-year trend
EBITDA margin
−0,3 %
This company
15,8 %
Market median
This company
Market median
102% below market
2020
2024
Equity ratio
11,0 %
This company
38,2 %
Market median
This company
Market median
71% below market
2020
2024
Return on equity
9,3 %
This company
18,4 %
Market median
This company
Market median
49% below market
2020
2024
Net profit margin
0,9 %
This company
8,1 %
Market median
This company
Market median
89% below market
2020
2024
Asset turnover
1,18×
This company
1,12×
Market median
This company
Market median
5% above market
2020
2024
Debt / equity
8,08×
This company
0,62×
Market median
This company
Market median
>999% above market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
View
PDF
More on Geno R&D AS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
